Intelligent Cartilage Repair Systems

Publication ID: 24-11857576_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Cartilage Repair Systems,” Published Technical Disclosure No. 24-11857576_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857576_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,576.

Summary of the Inventive Concept

The present inventive concept integrates advanced technologies, such as AI, IoT, blockchain, and 3D printing, with the original patented composition and method for repairing cartilage defects, enabling personalized, data-driven, and secure cartilage repair solutions.

Background and Problem Solved

The original patent addresses the limitation of spontaneous repair of chondral lesions. However, it does not provide a comprehensive solution for personalized treatment planning, secure data management, and real-time monitoring. The new inventive concept solves these problems by combining the original patented composition and method with synergistic technologies.

Detailed Description of the Inventive Concept

The inventive concept comprises a composition of cultured allogeneic cells and a resorbable collagen membrane, integrated with AI, IoT, blockchain, and 3D printing technologies. The AI module predicts optimal implantation sites and monitors post-implantation recovery. Machine learning algorithms analyze patient medical history to identify customized treatment plans. The blockchain-based data management platform securely stores and shares patient data. The IoT sensor monitors implant performance and provides real-time feedback. The 3D-printed cartilage scaffold features a lattice structure created using advanced materials and 3D printing techniques, promoting optimal tissue regeneration and integration.

Novelty and Inventive Step

The new claims introduce the novel combination of the original patented composition and method with advanced technologies, enabling personalized, data-driven, and secure cartilage repair solutions. This integration of technologies is non-obvious and provides a significant improvement over the original patent.

Alternative Embodiments and Variations

Alternative embodiments include integrating the composition and method with other AI algorithms, using different types of sensors or data management platforms, or applying the inventive concept to other tissue repair applications. Variations may include modifying the lattice structure of the 3D-printed scaffold or using different materials for the scaffold.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the fields of orthopedics, sports medicine, and tissue engineering. The market for cartilage repair solutions is growing, and the integration of advanced technologies provides a competitive advantage.

Field of Art

Regenerative medicine, tissue engineering, specifically cartilage repair technologies involving cell culture, biomaterials, and medical device integration

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or regenerative medicine specialist with expertise in cell culture techniques, biomaterial design, medical device development, and emerging digital health technologies, holding advanced degrees and practical experience in translating laboratory research into clinical applications

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies with existing cartilage repair compositions represents a predictable evolution of medical treatment strategies. The source patent provides a foundational composition of allogeneic cells and collagen membrane, which naturally invites technological augmentation for improved patient outcomes. Emerging trends in personalized medicine and digital health suggest that AI, IoT, and data management technologies are logical extensions for monitoring and optimizing medical interventions.

Obvious Combinations & Variations

Source Patent Element
Cryogenically frozen chondrocyte cell bank samples
PTD Variation
Machine learning algorithms analyzing patient medical history to customize cell selection and treatment protocols
Obviousness Reasoning
Predictable application of data analysis techniques to existing cell-based therapeutic approaches, representing a known method of personalizing medical treatments
Source Patent Element
Resorbable collagen membrane for cartilage repair
PTD Variation
3D-printed scaffold with advanced lattice structure to enhance tissue regeneration
Obviousness Reasoning
Known technique of using advanced manufacturing to optimize biomaterial design, with predictable improvements in tissue integration and healing
Source Patent Element
Allogeneic cell implantation method
PTD Variation
IoT sensor integration for real-time performance monitoring of implanted cells
Obviousness Reasoning
Predictable extension of medical device technologies to track and validate therapeutic interventions, representing a logical progression in patient monitoring
Source Patent Element
Cartilage defect treatment composition
PTD Variation
Blockchain-based secure data management platform for patient information
Obviousness Reasoning
Known approach to enhancing medical data security and interoperability, representing a standard technological improvement in healthcare information systems
Source Patent Element
Chondrocyte culture and implantation method
PTD Variation
AI module predicting optimal implantation sites based on patient-specific imaging and medical data
Obviousness Reasoning
Predictable application of machine learning to medical imaging and treatment planning, representing a standard technological enhancement in precision medicine
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857576 and the published technical disclosure, a person having ordinary skill in the art would find the integration of digital technologies with cartilage repair compositions to be an obvious and predictable extension of existing medical treatment strategies. The disclosed variations represent routine applications of known technological approaches to enhance monitoring, personalization, and efficacy of established cell-based therapeutic methods.

Original Patent Information

Patent NumberUS 11,857,576
TitleCompositions and methods for repairing cartilage defects
Assignee(s)Vericel Corporation